Latest Threads

Dubai Investments, through its subsidiary Globalpharma, has signed a Memorandum of Understanding (MoU) with Angola’s Ministry of Health to establish a pharmaceutical manufacturing facility in DIP Angola. This agreement, signed during a UAE delegation visit to Angola, aims to enhance bilateral relations and promote local medicine production. The initiative is expected to create jobs, boost healthcare self-sufficiency, and reduce reliance on imported medical products in Angola. The MoU was signed by Khalid Bin Kalban, CEO of Dubai Investments, and Dr. Nídia da Silva Jorge Saiundo from Angola’s Ministry of Health. The collaboration is part of a broader strategy to foster sustainable healthcare development and economic growth in Angola, with Globalpharma leveraging its expertise in producing high-quality medicines. Angola’s Ministry of Health will support the project by coordinating with government bodies for necessary approvals.

Emirates Central Cooling Systems Corporation PJSC (Empower) announced the approval of 23,339 No Objection Certificate (NOC) applications in the first half of 2025, reflecting an 18.7% increase from the same period in 2024. This growth indicates strong client relationships and rising demand for Empower's services. The company emphasizes its commitment to efficient service delivery, operational streamlining, and support for development and construction processes in Dubai. Empower's NOC service, accessible via its website, aims to facilitate easy application submission, reduce violations, and enhance project efficiency. CEO Ahmad Bin Shafar highlighted the alignment of these services with Dubai's vision for advanced urban development and the UAE's sustainability goals, noting the positive impact on energy efficiency and quality of life for Empower's 148,000 customers.